<DOC>
	<DOC>NCT01610531</DOC>
	<brief_summary>Melanoma is nowadays an important public health problem because its growing incidence. Mass screening for melanoma is not recommended worldwide because of its low cost-effectiveness. Nevertheless targeted screening for patients at high risk for melanoma is promoted. This study is designed to assess the effectiveness and the acceptability of a melanoma targeted screening of melanoma, to estimate the risk function to develop a melanoma among patients at high risk according to the SAMScore and to estimate the ratio cost/ efficacy of the melanoma targeted screening. A cohort of 7700 patients is carried out in 2 departments covered by a registry of cancers. The recruitment had began in April 2011. Patients assessed at high risk according to the SAMScore were proposed a skin examination by their GP every year.</brief_summary>
	<brief_title>COPARIME: Pilot Study of a Target Detection of Malignant Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>patients more than 18 years old, consulting their GP, assessed at risk for melanoma according to the SAMScore signed the consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Cohort</keyword>
	<keyword>Melanoma</keyword>
	<keyword>targeted screening</keyword>
	<keyword>risks function</keyword>
	<keyword>cost effectiveness</keyword>
</DOC>